Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Halozyme Therapeutics (HALO) Q3 2023 Earnings
HALO
8
Aug
Confirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
0.47
0.56
0.65
0.74
Details
Expected EPS
0.62
Actual EPS
0.74
Surprise EPS
0.12
Surprise Percent
+19.35%
Description
Halozyme Therapeutics (HALO) has reported earnings of 0.74 per share for Q3 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login